Meihua International Medical Technologies Co., Ltd. (MHUA)
USD 0.27
(-44.94%)
USD 0.27
(-44.94%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 15.77 Million USD | -1.29% |
| 2022 | 16.12 Million USD | -37.71% |
| 2021 | 26.88 Million USD | 7.91% |
| 2020 | 23.98 Million USD | 20.33% |
| 2019 | 19.89 Million USD | 1.02% |
| 2018 | 19.74 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 3.09 Million USD | 0.0% |
| 2024 Q1 | 3.09 Million USD | 7.51% |
| 2023 Q4 | 2.87 Million USD | 0.0% |
| 2023 Q1 | 4.69 Million USD | 98.61% |
| 2023 FY | - USD | -1.29% |
| 2023 Q3 | 2.87 Million USD | -69.41% |
| 2023 Q2 | 9.39 Million USD | 100.13% |
| 2022 Q2 | 5.69 Million USD | 0.0% |
| 2022 FY | - USD | -37.71% |
| 2022 Q1 | 5.69 Million USD | -24.49% |
| 2022 Q4 | 2.36 Million USD | 0.0% |
| 2022 Q3 | 2.36 Million USD | -58.48% |
| 2021 Q4 | 7.54 Million USD | 0.0% |
| 2021 Q3 | 7.54 Million USD | 27.88% |
| 2021 Q2 | 5.89 Million USD | 0.0% |
| 2021 Q1 | 5.89 Million USD | 7.78% |
| 2021 FY | - USD | 7.91% |
| 2020 Q2 | 6.52 Million USD | -0.0% |
| 2020 FY | - USD | 20.33% |
| 2020 Q4 | 5.47 Million USD | 0.0% |
| 2020 Q3 | 5.47 Million USD | -16.08% |
| 2020 Q1 | 6.52 Million USD | 88.6% |
| 2019 Q1 | 6.49 Million USD | 0.0% |
| 2019 Q4 | 3.45 Million USD | 0.0% |
| 2019 Q3 | 3.45 Million USD | -46.72% |
| 2019 Q2 | 6.49 Million USD | -0.0% |
| 2019 FY | - USD | 1.02% |
| 2018 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -45.63 Million USD | 134.56% |
| AngioDynamics, Inc. | -14.29 Million USD | 210.345% |
| AtriCure, Inc. | -8.1 Million USD | 294.482% |
| Avinger, Inc. | -16.34 Million USD | 196.48% |
| Azenta, Inc. | 55.15 Million USD | 71.405% |
| BioLife Solutions, Inc. | -45.23 Million USD | 134.861% |
| The Cooper Companies, Inc. | 882.8 Million USD | 98.214% |
| Daxor Corporation | 329.74 Thousand USD | -4682.723% |
| Ekso Bionics Holdings, Inc. | -13.19 Million USD | 219.492% |
| Femasys Inc. | -13.16 Million USD | 219.751% |
| GlucoTrack, Inc. | -7.09 Million USD | 322.402% |
| Harvard Bioscience, Inc. | 9.49 Million USD | -66.128% |
| Hologic, Inc. | 1.29 Billion USD | 98.783% |
| ICU Medical, Inc. | 307.69 Million USD | 94.875% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 99.341% |
| KORU Medical Systems, Inc. | -9.39 Million USD | 267.779% |
| LeMaitre Vascular, Inc. | 48.99 Million USD | 67.809% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 339.851% |
| Innovative Eyewear, Inc. | -6.57 Million USD | 339.851% |
| Masimo Corporation | 236.7 Million USD | 93.337% |
| Microbot Medical Inc. | -10.63 Million USD | 248.303% |
| Merit Medical Systems, Inc. | 231.44 Million USD | 93.186% |
| Nephros, Inc. | -1.37 Million USD | 1243.622% |
| NovoCure Limited | -175.86 Million USD | 108.967% |
| NEXGEL, Inc. | -2.73 Million USD | 677.676% |
| NEXGEL, Inc. | -2.73 Million USD | 677.676% |
| Singular Genomics Systems, Inc. | -86.49 Million USD | 118.233% |
| OraSure Technologies, Inc. | 76.15 Million USD | 79.292% |
| Pro-Dex, Inc. | 8.33 Million USD | -89.254% |
| Pulse Biosciences, Inc. | -42.36 Million USD | 137.224% |
| Predictive Oncology Inc. | -13.18 Million USD | 219.637% |
| Precision Optics Corporation, Inc. | -2.51 Million USD | 727.821% |
| QuidelOrtho Corporation | 545.6 Million USD | 97.11% |
| Repligen Corporation | 124.29 Million USD | 87.312% |
| Sanara MedTech Inc. | -289.09 Thousand USD | 5555.107% |
| STAAR Surgical Company | 33.22 Million USD | 52.528% |
| Sharps Technology, Inc. | -8.98 Million USD | 275.611% |
| Utah Medical Products, Inc. | 24.8 Million USD | 36.422% |
| DENTSPLY SIRONA Inc. | 232 Million USD | 93.202% |
| Jin Medical International Ltd. | 3.44 Million USD | -358.062% |